Total Payments
$1,350
2024 Payments
$259.79
Companies
11
Transactions
25
Medicare Patients
2,357
Medicare Billing
$636,869
Payment Breakdown by Category
Food & Beverage$1,160 (86.0%)
Education$189.60 (14.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,160 | 24 | 86.0% |
| Education | $189.60 | 1 | 14.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $746.65 | 9 | $0 (2019) |
| ABBVIE INC. | $140.88 | 2 | $0 (2024) |
| Inari Medical, Inc. | $131.50 | 1 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $127.35 | 2 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $95.09 | 4 | $0 (2019) |
| US WorldMeds, LLC | $27.43 | 2 | $0 (2018) |
| Saol Therapeutics Inc. | $22.03 | 1 | $0 (2019) |
| Grifols USA, LLC | $19.56 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $14.50 | 1 | $0 (2017) |
| Tactile Systems Technology Inc | $13.34 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $259.79 | 3 | Inari Medical, Inc. ($131.50) |
| 2023 | $139.94 | 2 | Merz Pharmaceuticals, LLC ($104.76) |
| 2019 | $204.51 | 6 | Allergan Inc. ($138.30) |
| 2018 | $246.17 | 8 | Allergan Inc. ($135.30) |
| 2017 | $499.55 | 6 | Allergan Inc. ($473.05) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Musculoskeletal | ||||||
| 06/18/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $131.50 | General |
| Category: VTE | ||||||
| 05/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $105.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $35.18 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/16/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $104.76 | General |
| Category: Musculoskeletal | ||||||
| 11/14/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $126.54 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Pulmonology | ||||||
| 04/15/2019 | Saol Therapeutics Inc. | Lioresal (baclofen) (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Severe Spasticity | ||||||
| 03/04/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/28/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 12/03/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 11/28/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $50.63 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 10/22/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/20/2018 | US WorldMeds, LLC | MYOBLOC (Biological) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Neurology | ||||||
| 06/25/2018 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 05/21/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/07/2018 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $96.00 | General |
| 01/03/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/27/2017 | Allergan Inc. | BOTOX CHRONIC MIGRAINE (Drug) | Food and Beverage | In-kind items and services | $88.00 | General |
| Category: ANTI-MIGRAINE | ||||||
| 06/21/2017 | US WorldMeds, LLC | MYOBLOC (Biological) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Neurology | ||||||
| 05/23/2017 | Allergan Inc. | BOTOX NEURO REHAB (Drug) | Food and Beverage | In-kind items and services | $51.39 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2017 | Allergan Inc. | BOTOX (Biological) | Education | In-kind items and services | $189.60 | General |
| 02/09/2017 | Allergan Inc. | BOTOX NEURO REHAB (Drug) | Food and Beverage | In-kind items and services | $144.06 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: OSTEOARTHRITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 574 | 14,167 | $354,999 | $149,253 |
| 2022 | 11 | 551 | 22,291 | $448,861 | $198,102 |
| 2021 | 10 | 567 | 19,643 | $388,235 | $176,197 |
| 2020 | 10 | 665 | 1,493 | $262,159 | $113,317 |
Total Patients
2,357
Total Services
57,594
Medicare Billing
$636,869
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 11 | 12,775 | $143,900 | $63,408 | 44.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 117 | 728 | $62,004 | $27,118 | 43.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 112 | 251 | $34,750 | $15,114 | 43.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 103 | 114 | $40,584 | $15,049 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 152 | $38,000 | $14,112 | 37.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 109 | 116 | $23,509 | $9,990 | 42.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $7,152 | $2,495 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $5,100 | $1,968 | 38.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 12 | 21,000 | $210,000 | $102,966 | 49.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 92 | 618 | $78,486 | $32,846 | 41.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 85 | 196 | $35,868 | $14,966 | 41.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 87 | 94 | $33,464 | $14,010 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 128 | $32,000 | $11,511 | 36.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 88 | 94 | $17,672 | $7,361 | 41.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 56 | 58 | $11,020 | $4,334 | 39.3% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 11 | 33 | $11,847 | $3,756 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 23 | $7,820 | $2,723 | 34.8% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 11 | 35 | $5,320 | $2,130 | 40.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $5,364 | $1,498 | 27.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 11 | 18,500 | $185,000 | $87,541 | 47.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 90 | 482 | $61,214 | $26,429 | 43.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 82 | 189 | $34,587 | $14,895 | 43.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 84 | 89 | $31,684 | $13,707 | 43.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 128 | $24,802 | $11,802 | 47.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 96 | 101 | $19,190 | $7,776 | 40.5% |
About Pradeep Gnanapragasam, M.D.,
Pradeep Gnanapragasam, M.D., is a Physical Medicine & Rehabilitation healthcare provider based in Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1750677589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Pradeep Gnanapragasam, M.D., has received a total of $1,350 in payments from pharmaceutical and medical device companies, with $259.79 received in 2024. These payments were reported across 25 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,160).
As a Medicare-enrolled provider, Gnanapragasam has provided services to 2,357 Medicare beneficiaries, totaling 57,594 services with total Medicare billing of $636,869. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Lafayette, IN
- Active Since 06/20/2011
- Last Updated 04/17/2023
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1750677589
Products in Payments
- BOTOX (Biological) $438.24
- BOTOX NEURO REHAB (Drug) $195.45
- FLOWTRIEVER CATHETER, S (Device) $131.50
- Xeomin (Biological) $127.35
- BOTOX (Drug) $126.54
- NUEDEXTA (Drug) $95.09
- BOTOX CHRONIC MIGRAINE (Drug) $88.00
- BOTOX THERAPEUTIC (Biological) $39.30
- MYOBLOC (Biological) $27.43
- Lioresal (baclofen) (Drug) $22.03
- Prolastin-C Liquid (Biological) $19.56
- SYNVISC-ONE (Device) $14.50
- FLEXITOUCH (Device) $13.34
- FARXIGA (Drug) $11.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Lafayette
Dr. Michael Tracy, Do, Ms, DO, MS
Physical Medicine & Rehabilitation — Payments: $9,613
Physical Medicine & Rehabilitation $9,613
Dr. Mark Griffith, Md, MD
Physical Medicine & Rehabilitation — Payments: $5,981
Physical Medicine & Rehabilitation $5,981
John Fruge, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,300
Physical Medicine & Rehabilitation $3,300
Dr. Michael Mciver, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $2,833
Physical Medicine & Rehabilitation $2,833
Koby Lanclos, Md, MD
Physical Medicine & Rehabilitation — Payments: $1,127
Physical Medicine & Rehabilitation $1,127
Kevin Lasseigne, Md, MD
Physical Medicine & Rehabilitation — Payments: $787.08
Physical Medicine & Rehabilitation $787.08